Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...

On a warm summer afternoon, when your throat runs dry, reaching for a glass of water might feel like the most natural thing ...

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18, offering both glycemic control and weight loss ...

When we feed the body correctly, we can influence the same systems that drugs like Mounjaro target - helping regulate ...

Beans are touted as a star ingredient in plant-based meals for their protein, zinc, and iron content. Read on to find more ...

Medicine, lifestyle changes, and surgery can return glucose levels to normal or nearly normal in some type 2 diabetes ...

Adolescents and young adults are increasingly using GLP-1 receptor agonists for weight management, raising concerns among ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...

This study reveals that adequate dietary fiber intake is crucial for lowering obesity risk and mortality, supporting its role ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

Weight-loss drugs offer initial benefits but often lead to weight regain after discontinuation. Bariatric surgery provides lasting metabolic changes and better long-term health outcomes for obesity ...